MO · 10-Q · 2026Q3 · Full report

Settlement and FDA Payments

ALTRIA GROUP, INC. · 2026-10-29 · Importance 66 · Surprise 40 · From source text

Altria estimated average charges to cost of sales of $3.0 billion annually for the next three years for State Settlement Agreement payments and FDA user fees, based on current agreements and estimates. Payments for these items totaled approximately $2.6 billion in the first nine months of 2026, compared with $2.9 billion in the same 2025 period. Related cost-of-sales charges were $2.4 billion for the first nine months of 2026 versus $2.5 billion in 2025, including $0.8 billion in the third quarter of 2026 versus $0.9 billion a year earlier. State Settlement Agreement amounts are generally paid in April of the following year, while FDA user fees are generally paid in the quarter incurred.

Key facts

Impact estimates

metricdirectionstageexpectedbasis
operating_incomenegativecommitted-41.6%Altria estimated State Settlement Agreement and FDA user fee charges to cost of sales would average $3.0 billion annually for the next…
operating_incomepositiverealized+1.6%Altria recorded $2.4 billion of State Settlement Agreement and FDA user fee cost-of-sales charges for the nine months ended September 30,…
cashpositiverealized+0.9%Altria paid approximately $2.6 billion for State Settlement Agreements and FDA user fees in the nine months ended September 30, 2026,…